|

Cellgram-LC Clinical Trials

2 actively recruiting trials

Also known as: Autologous bone marrow-derived mesenchymal stem cell

Pipeline

Phase 3: 1

Top Sponsors

  • Pharmicell Co., Ltd.2

Indications

  • Alcoholic Cirrhosis2
  • Liver Disease2

Other2 trials

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Phase 3
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.